Safety and Efficacy of Cellular Drugs, Objective Response Rate of Subjects, Etc

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Safety and Efficacy of Cellular Drugs, Objective Response Rate of Subjects, Etc trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Active — Not RecruitingEarly Phase 1

NCT06572956

Clinical Study on the Safety and Efficacy of CAR-T/CAR-NK Cells in the Treatment of Recurrent Refractory or Unresectable…

To investigate the safety and efficacy of CAR-T/CAR-NK cells in patients with recurrent or unresectable solid tumors, including pancreatic cancer, prostate canc…

China10 participantsStarted 2024-03-21

Treatment: CAR-T/CAR-NK cell injection